Arsenic Trioxide

Product NDC
70860-217
11-digit product format
708600217
Labeler code
70860
Product ID
70860-217_80ae6afb-9ea9-466e-a9ba-5309224e7efa
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
arsenic trioxide
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Labeler
Athenex Pharmaceutical Division, LLC.
Application
ANDA209315
Marketing category
ANDA
Marketing start
2020-11-30
Marketing end
0000-00-00
Substance
ARSENIC TRIOXIDE
Active strength
1 mg/mL
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70860-217-102024-02-27C16284748780-11030e365-1153-111a-e063-dadaa90a10e2d9b3389d-bd95-4559-b3c7-099a57be8b1a
70860-217-102024-01-30C16284748780-11030e365-1153-111a-e063-dadaa90a10e2d9b3389d-bd95-4559-b3c7-099a57be8b1a

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70860-217-10ML - Milliliter70860-217d8c264d0-d022-4ad8-a7e1-ba646f0e36ac12021-03-02

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70860-217-10708600217101 VIAL in 1 CARTON (70860-217-10) > 10 mL in 1 VIAL1 vial2020-11-300000-00-00NoNoCurrent